Braskem S.A.

As of June 30, 2026, Braskem S.A. Cedear Each 2 Repr 1 ADR (A carries a market capitalization of 1.46T, placing it among publicly traded companies globally. Its enterprise value stands at 19.21T, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Braskem S.A. Cedear Each 2 Repr 1 ADR (A's next confirmed earnings release is scheduled for November 12, 2026.

As of June 30, 2026, Braskem S.A. Cedear Each 2 Repr 1 ADR (A has 747.73M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 0.07, and the price-to-book ratio stands at -0.40.

As of June 30, 2026, Braskem S.A. Cedear Each 2 Repr 1 ADR (A trades at an EV/EBITDA multiple of 8.99 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 0.95 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 23.35 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 19.21T versus a market cap of 1.46T, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Braskem S.A. Cedear Each 2 Repr 1 ADR (A maintains a current ratio of 0.77, meaning it holds 0.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -521.87, indicating conservative leverage, while an interest coverage ratio of 1.32 demonstrates limited ability to service its debt obligations.

These figures cover the twelve months ended June 30, 2026. Return on invested capital (ROIC) is negative at -23.15, so the business is destroying capital rather than earning a return above its cost of capital. Return on assets (ROA) is negative at -6.50, reflecting losses generated across the asset base. Return on capital employed (ROCE) is negative at -53.58, pointing to unprofitable operations over the period. The company generates approximately 2.45B in revenue per employee across its workforce of 8,270.25, a quick read on workforce productivity versus industry peers. Inventory turnover of 4.84 indicates how many times Braskem S.A. Cedear Each 2 Repr 1 ADR (A sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Braskem S.A. Cedear Each 2 Repr 1 ADR (A recorded 2.30T in income tax expense. That works out to an effective tax rate of 579.68, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 396.92B, leaving -1.59T in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, Braskem S.A. Cedear Each 2 Repr 1 ADR (A's stock has declined approximately 32.67% over the past 52 weeks. The 50-day moving average sits at 1,429.56, while the 200-day moving average is 2,323.97.

Over the twelve months ended June 30, 2026, Braskem S.A. Cedear Each 2 Repr 1 ADR (A generated 20.26T in revenue and converted that into -1.59T in net income, yielding earnings per share of -2,546.20. EBITDA reached 2.14T, while operating income came in at 890.27B.

As of June 30, 2026, Braskem S.A. Cedear Each 2 Repr 1 ADR (A holds 1.70T in cash and equivalents against 19.60T in total debt, resulting in a net debt position of 17.31T. Total book value stands at -3.61T, with working capital of -2.50T providing operational flexibility.

Braskem S.A. Cedear Each 2 Repr 1 ADR (A produced -1.67T in operating cash flow over the twelve months ended June 30, 2026. After subtracting -901.18B in capital expenditures, free cash flow totaled -2.57T - equivalent to -3,432.04 per share.

Over the twelve months ended June 30, 2026, Braskem S.A. Cedear Each 2 Repr 1 ADR (A posted a gross margin of 8.92, reflecting its pricing power and cost economics. The operating margin of 4.39 and net profit margin of -7.85 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -176.00: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -81.86, meaning Braskem S.A. Cedear Each 2 Repr 1 ADR (A raised more capital through share issuance and new debt than it returned via dividends and buybacks.

As of June 30, 2026, Braskem S.A. Cedear Each 2 Repr 1 ADR (A has an Altman Z-Score of 0.61, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.